Loading the session
Loading the session
Loading instrument
$39.67
+0.65%DelayedDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 20:17 IST · A quote does not mean the product is available to trade on your account.
In brief
Questions investors ask
Quotes run fifteen minutes behind.
1 month: +11.1% (SPY −1.6%, XLK −12.6%). 3 months: +6.0% (SPY −0.4%, XLK −5.1%). 1 year: +14.2% (SPY +13.6%, XLK +20.1%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: OMCL, SPY and XLK · as of 4 Nov 2026
The 4 Nov 2026 gain of 11.1% was 5.3× its average daily move of 2.1% over the past year, and its largest one-day gain since 28 Apr 2026.
Daily closes, split-adjusted · as of 4 Nov 2026
The 4 Nov 2026 close of $39.41 was 13.4% above its 50-day average ($34.76) and 1.5% above its 200-day average ($38.84). It has closed above the 200-day for 1 session, since 4 Nov 2026. The 50-day average crossed below the 200-day on 17 Aug 2026, 56 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
3.3M shares were sold short at the 15 Oct 2026 settlement, 7.2% of the 45.5M shares outstanding; covering them would take 7.5 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Closed at $39.41 on 4 Nov 2026: 28.3% below the 52-week high of $55.00 (13 Jan 2026) and 24.1% above the low of $31.75 (31 Mar 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Price return, split-adjusted
At the 4 Nov 2026 close
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
October 30, 2024
+32.23%August 1, 2024
+33.00%November 2, 2022
−34.52%